(redirected from Gralise)
Also found in: Dictionary, Medical.
Graphic Thesaurus  🔍
Display ON
Animation ON
  • noun

Synonyms for gabapentin

an anticonvulsant (trade name Neurontin) used to control some types of seizures in the treatment of epilepsy

References in periodicals archive ?
The FDA denied Depomed's designation request on the ground that Depomed did not present a compelling enough case in its current application to bolster the contention that Gralise would deliver the potential beneficial effects the sponsor had hypothesized.
Fast forward four years: By 2010, Abbott Labs had acquired the rights to Gralise and renewed the previous request for orphan designation, arguing that while Neurontin is arguably the "same" drug as Gralise, it had never received exclusivity, and therefore Abbott was not required to provide a plausible hypothesis of clinical superiority in its renewed designation request.
The Gralise Starter Pack is designed as a titration therapy, bringing patients from an initial dose of 300mg on day one progressing to the maintenance dose of 1800mg by day 30.
24 January 2012 - Depomed Inc (NASDAQ:DEPO), a US-based specialty pharmaceutical company, said on Monday that it had been informed by Actavis Elizabeth LLC that Actavis had sought approval from the US Food and Drug Administration (FDA) to market a generic version of Gralise (gabapentin), 300 mg and 600 mg tablets.
Actavis' application is based on the assumption that Depomed's six US patents for Gralise listed in the FDA Orange Book, the latest of which is valid through 2024, will not be infringed by the generic version of the product, or are invalid or unenforceable.
11 October 2011 - US specialty pharmaceutical company Depomed Inc (NASDAQ:DEPO) said yesterday that its GRALISE (gabapentin) tablets are now available as a new once-daily treatment for postherpetic neuralgia (PHN), the pain following healing of the rash associated with shingles.
Despite its lack of approval specifically for painful diabetic neuropathy, Depomed's Gralise (gabapentin GR) earns proprietary gold standard status in 2015 based on a once-daily dosing regimen and a low incidence of neurological side effects in clinical trials--attributes which are valued by interviewed thought leaders.
Drug Brand Names Acetaminophen * Tylenol Lithium * Eskalith, Lithobid Amitriptyline * Elavil, others Methotrexate * Rheumatrex, Amoxapine * Asendin Trexall Carbamazepine * Tegretol, Milnacipran * Savella Carbatrol, others Nortriptyline * Aventyl, Clomipramine * Anafranil Pamelor Desipramine * Norpramin Olanzapine * Zyprexa Duloxetine * Cymbalta Oxcarbazepine * Trileptal Fluoxetine * Prozac Pregabalin * Lyrica Gabapentin * Neurontin, Topiramate * Topamax, Gralise Topiragen Imipramine * Tofranil Venlafaxine * Effexor Lamotngine * Lamktal Ziprasidone * Geodon
Kevin Weber will lead all marketing activities of the company including the launch of Gralise (gabapentin), its once-daily formulation of gabapentin for the management of postherpetic neuralgia.
M2 PHARMA-May 9, 2011-Depomed's Gralise shows similar efficacy in patients 65 years old and over compared with patients overall(C)2011 M2 COMMUNICATIONS
M2 EQUITYBITES-October 11, 2011-Depomed Inc unveils new once-daily GRALISE for after-shingles pain(C)2011 M2 COMMUNICATIONS http://www.
They are Gralise (gabapentin extended release), Qutenza (capsaicin), Lyrica (pregabalin), Neurontin (gabapentin), and Lidoderm/Versatis (lidocaine).
The company added the net income for the second quarter of 2010 included the one-time recognition of a USD10m milestone payment from Abbott Products Inc related to the FDA's acceptance for review of the New Drug Application for Gralise (gabapentin).
M2 EQUITYBITES-June 21, 2011-Depomed Inc selects inVentiv Selling Solutions for sales of Gralise for PHN(C)2011 M2 COMMUNICATIONS http://www.
M2 EQUITYBITES-January 31, 2011-Depomed Inc awarded US FDA approval of GRALISE for PHN(C)2011 M2 COMMUNICATIONS http://www.